Tranexamic acid to reduce blood loss during C-section
Treatments studied
Part of Blood & lymphatic, Women’s health & pregnancy clinical trials.
This study tests if giving tranexamic acid (a medicine that helps blood clot) before C-section can reduce bleeding during and after surgery. It may help women who have higher risks of bleeding during delivery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 37 to 42 weeks pregnant (full-term).
- You are scheduled for a C-section for reasons like placenta previa, severe preeclampsia, large fibroids, large baby, too much amniotic fluid, having had 5 or more previous births, or prolonged labor.
- You have not had an allergic reaction to tranexamic acid before.
- You do not have a history of blood clots, stroke, heart attack, or seizures.
- You do not have serious heart, kidney, or liver disease.
- You are not taking blood thinners or antiplatelet medicine in the week before surgery.
- You do not have specific pregnancy complications like placenta accreta, placental abruption, eclampsia, HELLP syndrome, or multiple babies (twins or more).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medicine called tranexamic acid before a cesarean section (c-section) can help reduce the amount of blood loss during the surgery. It may be an option for women having either a planned or unplanned c-section.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
This study tests whether applying a medicine called tranexamic acid directly to the uterus during a scheduled cesarean can reduce bleeding. It may help women who are having their first or second cesarean delivery.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This trial is for women having their second or third planned c-section. It tests if giving a medicine called tranexamic acid helps prevent heavy bleeding. The medicine is safe and commonly used to reduce bleeding.
This study tests whether tranexamic acid, a drug that helps blood clot, can prevent heavy bleeding after a C-section in women who have certain risk factors. If you are at higher risk for postpartum hemorrhage, this trial may help you avoid dangerous blood loss.
Hear when a new Pregnant Women Undergoing Cesarean Delivery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.